We've merged with Palleos Healthcare to form a wide-reaching European CRO.
Find out more
OCT Clinical will be exhibiting with a booth at the American Society of Clinical Oncology (ASCO) Annual Meeting 2024, taking place from May 31 - June 4 in Chicago.
ASCO is the world's leading professional organization for oncology professionals, and its Annual Meeting is the premier event in the field. This year's meeting promises to be an unparalleled opportunity to immerse yourself in the latest advancements in cancer research, treatments, and clinical insights.
We're excited to connect with oncology professionals from around the globe, forge collaborations, and contribute to shaping the future of cancer care.
Get in touch with Anna Yanaeva at ayanaeva@oct-clinicaltrials.comto book a meeting or just visit our Booth #37121 to discuss your Oncology trials opportunities in Eastern Europe.
OCT Clinical is now operating under Palleos Healthcare brand name.
“The merger will undoubtedly create significant synergies, not just doubling but squaring the expertise of both companies”, Philip Räth, Ph.D., managing director at Palleos, said in the release.
“OCT Clinical is proud to join forces with palleos healthcare, as it has an excellent reputation in the industry it serves. Now we can offer tailored solutions to our clients to meet their diverse clinical research needs and accelerate the time of bringing their products to market”, Dmitry Sharov, CEO at OCT Clinical.